Sfoglia per Rivista NATURE REVIEWS. GASTROENTEROLOGY & HEPATOLOGY
Big data in IBD: a look into the future
2019-01-01 Olivera, P; Danese, S; Jay, N; Natoli, G; Peyrin-Biroulet, L
Biologic agents for IBD: practical insights
2015-01-01 Danese, S; Vuitton, L; Peyrin-Biroulet, L
Biosimilars in IBD: from theory to practice
2017-01-01 Danese, S; Bonovas, S; Peyrin-Biroulet, L
COLONOSCOPY Cold snaring diminutive polyps-the thinner the better!
2015-01-01 Hassan, C; Repici, A
COVID-19 and endoscopy: implications for healthcare and digestive cancer screening
2020-01-01 Gralnek Ian, M.; Hassan, C; Dinis-Ribeiro, Mario
CROHN'S DISEASE Bacterial clearance in Crohn's disease pathogenesis
2010-01-01 Fava, F; Danese, S
The day after COVID-19 in IBD: how to go back to 'normal'
2020-01-01 Danese, Silvio; Sands, Bruce; Ng, Siew C; Peyrin-Biroulet, Laurent
Evolving therapeutic goals in ulcerative colitis: towards disease clearance
2020-01-01 Danese, S; Roda, G; Peyrin-Biroulet, L
First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?
2013-01-01 Peyrin-Biroulet, L; Fiorino, G; Buisson, A; Danese, S
The gasdermin protein family: emerging roles in gastrointestinal health and disease
2023-01-01 Privitera, Giuseppe; Rana, Nitish; Armuzzi, Alessandro; Pizarro, Theresa T.
Head-to-head trials in inflammatory bowel disease: past, present and future
2020-01-01 Pouillon, Lieven; Travis, Simon; Bossuyt, Peter; Danese, Silvio; Peyrin-Biroulet, Laurent
IBD Adalimumab for ulcerative colitis-is the glass half empty or half full?
2011-01-01 Armuzzi, A; Pugliese, D
IBD Golimumab in ulcerative colitis: a 'menage a trois' of drugs
2013-01-01 Danese, S
IBD IN 2013 Enriching the therapeutic armamentarium for IBD
2014-01-01 Danese, S; Peyrin-Biroulet, L
IBD Mucosal healing-EXTENDing our knowledge in Crohn's disease
2012-01-01 Danese, S; Peyrin-Biroulet, L
IBD Of mice and men-shedding new light on IL-13 activity in IBD
2011-01-01 Danese, S
IBD To switch or not to switch: that is the biosimilar question
2017-01-01 Danese, S; Peyrin-Biroulet, L
IBD: Infliximab dose optimization in IBD-proactive or reactive?
2014-01-01 Armuzzi, Alessandro; Felice, C.
JAK-STAT Pathway Targeting for the Treatment of Inflammatory Bowel Disease
2020-01-01 Salas, A; Hernandez-Rocha, C; Duijvestein, M; Faubion, W; Mcgovern, D; Vermeire, S; Vetrano, S; Vande Casteele, N
Management of IBD during the COVID-19 outbreak: resetting clinical priorities
2020-01-01 Danese, Silvio; Cecconi, Maurizio; Spinelli, Antonino
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile